Wyeth Wins FDA Approval for Kidney Cancer Drug

Wyeth's drug Torisel won U.S. approval to treat patients with a type of advanced kidney cancer known as renal cell carcinoma, the Food and Drug Administration said.

The FDA said studies showed those taking only Torisel, also known by its chemical name temsirolimus, "showed a significant improvement in overall survival."

Contact U.S. News


    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

Don't Miss

U.S. Video